Atlanta Braves Holdings insider files Form 144 for 30,000 Series C shares

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. (BATRK) – Form 144 filing discloses a proposed insider sale of the company’s Series C common stock.

Shares to be sold: 30,000. Aggregate market value: $1,365,000. Approximate sale date: 06/20/2025. Broker: UBS Financial Services Inc., 11 Madison Ave., New York, NY 10010. Exchange: NASDAQ. Total Series C shares outstanding: 51,297,110, making the proposed transaction roughly 0.06 % of the class.

The seller proposes to dispose of the shares that were acquired by exercising stock options on 06/20/2025; the consideration paid was cash. The filing also details prior sales within the last three months by Derek Schiller at the same address (755 Battery Avenue SE, Atlanta, GA 30339):

• 72,505 shares sold on 06/11/2025 for gross proceeds of $3,117,767.01
• 40,000 shares sold on 06/18/2025 for gross proceeds of $1,760,000.00

Cumulatively, 112,505 shares have already been sold in the past quarter for $4,877,767.01, representing roughly 0.22 % of the outstanding Series C shares. Including the newly-noticed 30,000 shares, total potential dispositions reach 142,505 shares (≈0.28 % of the class) with an aggregate value in excess of $6.2 million.

The signer affirms no knowledge of undisclosed material adverse information and, if applicable, compliance with Rule 10b5-1 trading plans. No remarks, plan-adoption date, or additional issuer details were supplied in the filing.

Positive

• Small relative size: 30,000 shares equal approximately 0.06 % of Series C common stock, limiting market impact.
• Regulatory transparency: Filing complies with Rule 144, listing prior sales and affirming no undisclosed adverse information.

Negative

• Continued insider selling: Including earlier transactions, insiders have disposed of 112,505 shares in three months and plan another 30,000 shares.
• Lack of contextual remarks: The filing omits reasoning or 10b5-1 plan details, offering limited insight into sale motivation.

Insights

Securities Analyst

TL;DR: Insider plans to sell 30k BATRK shares; size is immaterial but adds to recent sales totaling 112.5k shares.

The Form 144 indicates a new planned sale of 30,000 Series C shares valued at $1.37 million. When combined with two recent sales (112,505 shares, $4.88 million), insider disposals over three months could reach 142,505 shares, or 0.28 % of the float. While the percentage is small and unlikely to impact liquidity, the steady pattern of selling may attract investor attention. The filing does not cite any negative company information, and the shares stem from option exercises, a common liquidity event. Overall, the disclosure is routine and does not materially alter the investment thesis.

Corporate Governance Expert

TL;DR: Routine Form 144; multiple recent insider sales noted, but volumes remain below materiality thresholds.

Rule 144 requires timely notice of intended insider sales. The filer fulfilled the rule by identifying share counts, market value, broker, and acquisition method (option exercise). Prior sales are properly aggregated. No remarks or 10b5-1 plan details were added; nonetheless, the representation of no undisclosed adverse information is standard. Given the tiny fraction of shares versus shares outstanding, governance risk appears low. Investors should continue monitoring, but no red flags emerge solely from this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series C Common Stock	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	30000	1365000.00	51297110	06/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series C Common Stock	06/20/2025	Exercise of Stock Options	Issuer			30000	06/20/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Derek Schiller 755 BATTERY AVENUE SE ATLANTA GA 30339	Series C Common Stock	06/11/2025	72505	3117767.01
Derek Schiller 755 BATTERY AVENUE SE ATLANTA GA 30339	Series C Common Stock	06/18/2025	40000	1760000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BATRK shares are proposed for sale under this Form 144?

The notice covers 30,000 Series C common shares.

What is the aggregate market value of the shares to be sold?

The 30,000 shares are valued at $1,365,000 based on the market price at filing.

When is the planned sale date for the BATRK shares?

The approximate sale date disclosed is 06/20/2025.

How many Series C shares does Atlanta Braves Holdings have outstanding?

The filing lists 51,297,110 Series C shares outstanding.

What insider sales of BATRK occurred in the past three months?

The seller Derek Schiller reported sales of 72,505 shares on 06/11/2025 and 40,000 shares on 06/18/2025 for total gross proceeds of about $4.88 million.

Which broker is handling the proposed transaction?

The broker named is UBS Financial Services Inc., 11 Madison Avenue, New York, NY 10010.